Bioflash
What an emerging drug company is doing to disrupt depression
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:28:41
- Mas informaciones
Informações:
Sinopsis
Dr. Atul Mahableshwarkar, hired last summer by BlackThorn Therapeutics as vice president of clinical development, talks about the South San Francisco drug company's attack on depression.
